Skip to Content

WATSON 460 (Glipizide 5 mg)

Pill with imprint WATSON 460 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 460

Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460  Front
Glipizide 5 mg WATSON 460  Back
Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460

Glipizide

Imprint
WATSON 460
Strength
5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, lactose anhydrous, microcrystalline cellulose, corn starch, stearic acid

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0460 Watson Pharmaceuticals, Inc.
54569-3841 A-S Medication Solutions, LLC (repackager)
63874-0316 Altura Pharmaceuticals Inc. (repackager)
55289-0806 PDRX Pharmaceuticals Inc. (repackager)
53002-0446 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.